Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuroimmunology
•
Child Neurology
•
Neuro-Ophthalmology
What is your approach to immune management in opsoclonus-myoclonus-ataxia syndrome?
Related Questions
What baseline visual testing, if any, do you recommend at diagnosis for patients with multiple sclerosis who deny visual complaints?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
How do you use aspirin in pre-symptomatic Sturge Weber patients?
Does persistent focal slowing without epileptiform discharges indicate increased seizure risk in patients without significant structural abnormalities?
How do you assess efficacy when trialing a patient with Rett syndrome on trofinetide (Daybue)?
Which interventions have you found effective for managing sensory sensitivities in children with autism spectrum disorder?
How would you work up and manage an isolated CN3 deficit with anisocoria?
Besides patient preference, what factors guide your decision to treat SeLECTs patients with antiseizure medications?
What is your approach to weaning phenobarbital and serial EEGs in patients with HIE after their perinatal seizures are under control?
How do you use amantadine and assess its efficacy for comatose pediatric patients?
